Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Sun Biomedical Technologies
Profile last edited on: 1/10/2007      CAGE: 1YMR2      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2002
First Award
2002
Latest Award
2005
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

430 Magna Vista
Ridgecrest, CA 93555
   (760) 371-5088
   EWFerguson@starband.net
   N/A
Location: Single
Congr. District: 23
County: Kern

Public Profile

Sun Biomedical Technologies researchs on early genetic responses to infectious diseases and environmental hazards, as well as development of peptide antibiotics for use as a Bacillus spore decontaminating agents, as detectors for Bacillus spores, and for potential treatment of anthrax spore inhalation and infection

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
2
Conversion Rate
66.67%
Phase I Dollars
$214,286
Phase II Dollars
$1,459,349
Total Awarded
$1,673,635

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2005 2 Army $799,843
Project Title: High-Throughput Proteomics Strategy for Detection and Identification of Biomarkers of Malaria Exposure
2004 1 NSF $75,000
Project Title: Sublancin 168 for Bacillus Spores Detection, Inactivation and Decontamination
2003 2 CBD $798,792
Project Title: Molecular Signatures of Biological Pathogens

Key People / Management

  Earl W Ferguson -- President

  Guck Ooi

Company News

There are no news available.